Navigating Challenges in Drug Discovery with Dr. Alfred Botchway
In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alfred Botchway, CEO of Attentive Science, to discuss his journey in biomedical science and the groundbreaking work being done at the intersection of AI, non-clinical safety, and drug discovery. Dr. Botchway shares his insights on the role of AI in refining toxicology studies, how stress impacts human health, and his experience founding companies like Xenometrics and Attentive Science.
The conversation dives deep into the complexities of Good Laboratory Practices (GLP), the importance of regulatory…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.